Tribenoside as an inhibitor of chemically induced histamine release.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology*; D002951:Citrates / Q000494:pharmacology; D004205:Cromolyn Sodium / Q000494:pharmacology; D004049:Diethylcarbamazine / Q000494:pharmacology; D005439:Flufenamic Acid / Q000494:pharmacology; D005947:Glucose / Q000494:pharmacology; D006027:Glycosides / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D006636:Histamine Release / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D008239:Lysine / Q000494:pharmacology; D008297:Male; D008407:Mast Cells / Q000187:drug effects*; D009536:Niacinamide / Q000494:pharmacology; D009552:Nikethamide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010693:Phloretin / Q000494:pharmacology; D012694:Serine / Q000494:pharmacology; D012964:Sodium; D012980:Sodium Salicylate / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D001593:Benzyl Compounds; D002951:Citrates; D006027:Glycosides; D006634:Histamine H1 Antagonists; D009536:Niacinamide; D009552:Nikethamide; D003189:p-Methoxy-N-methylphenethylamine; D012694:Serine; D005439:Flufenamic Acid; D000324:Adrenocorticotropic Hormone; D012964:Sodium; D013806:Theophylline; D010653:Phenylbutazone; D005947:Glucose; D008239:Lysine; D007545:Isoproterenol; D004205:Cromolyn Sodium; D010693:Phloretin; D004049:Diethylcarbamazine; D012980:Sodium Salicylate; D009638:Norepinephrine